J3300 HCPCS Level II code: Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
J3300 is the HCPCS code for “Injection, triamcinolone acetonide (triesence), preservative free, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
Short description: Triamcinolone a inj prs-free
HCPCS · United States
Notes for J3300
As CMS prints them, with any note J3300 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J3300 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2009
Where J3300 sits
- 1J codesDrugs administered other than orally
- 2Active code J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3300 mean?
J3300 is the HCPCS code for “Injection, triamcinolone acetonide (triesence), preservative free, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3300?
CMS lists J3300’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3300
All J codesJ3268Injection, delafloxacin, 1 mgJ3280Injection, thiethylperazine maleate, up to 10 mgJ3285Injection, treprostinil, 1 mgJ3290Injection, tranexamic acid, 5 mgJ3291Injection, tranexamic acid in sodium chloride, 5 mgJ3299Injection, triamcinolone acetonide (xipere), 1 mgJ3301Injection, triamcinolone acetonide, not otherwise specified, 10 mgJ3302Injection, triamcinolone diacetate, per 5 mgJ3303Injection, triamcinolone hexacetonide, per 5 mgJ3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgJ3305Injection, trimetrexate glucuronate, per 25 mgJ3310Injection, perphenazine, up to 5 mg